← Open Payments lookup

RYAN BROWN: Open Payments

NPI 1760826275 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$907 in 50 payments from 15 companies in 2025. Trend: 2023 $779 · 2024 $996 · 2025 $907

Food & beverage: $907
CompanyPaymentsAmount
ABBVIE INC.12$161
Merck Sharp & Dohme LLC5$121
PFIZER INC.5$91
Novo Nordisk Inc5$89
Amgen Inc.4$84
Lilly USA, LLC3$64
GlaxoSmithKline, LLC.3$55
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$52
Phathom Pharmaceuticals, Inc.3$39
Aimmune Therapeutics, Inc.1$36

Products named: GARDASIL 9, EVENITY, VRAYLAR, MOUNJARO, ELIQUIS, Ozempic, XIFAXAN, LAGEVRIO.

Industry payments across DE — which companies pay providers there.